BlogFeaturedViral vaccinesViral vectors Driving down COGs of viral vector-based biopharmaceuticals How do you keep cost of goods (COGs) for viral vector-based medicines within reason to…Aaron Ogdahl8 November 2022
BlogFeaturedViral vaccinesViral vectors Taking your adenoviral vector product from R&D to the clinic Adenoviruses have been shown to be very effective vehicles for delivering genetic material to cells…Claire Otjes25 April 2022
BlogFeaturedViral vaccinesViral vectors Adenovirus vectors: cutting edge delivery vehicles for gene therapy and vaccine development Adenovirus (Ad) vectors are used to develop gene therapy products and vaccines. Decades of research…Aaron Ogdahl11 April 2022
BlogFeaturedViral vaccinesViral vectors Adenoviral vector platform: past and current challenges Adenoviruses have been explored for gene therapy purposes for many decades. They are DNA viruses,…Aaron Ogdahl24 March 2022
BlogViral vectors Solving challenges in manufacturing viral vector based ATMPs Written by expert: Kai, Technical Lead The obstacles of viral vector production Over the last…Aaron Ogdahl28 February 2022
BlogViral vaccinesViral vectors Accelerating viral vector and vaccine development: beware the pitfalls of scale-up You’ve developed a candidate viral vaccine or viral vector product, and initial preclinical data are…tristan19 April 2021
BlogViral vectors Do fixed-bed bioreactors provide a solution to viral vector shortage? Written by expert: Yang, Bioprocess Scientist In 2017, the New York Times wrote an article…Claire Otjes27 January 2020
BlogViral vaccinesViral vectors Latest advancements in bioprocess intensification for efficient biopharmaceutical production Written by expert: Ahd, Director Project Management Current costs of biopharmaceutical manufacturing often prevent segments…Claire Otjes8 July 2019
BlogViral vectors Tackling the capacity bottleneck in downstream processing of viral vectors Written by expert: Evert, Associate Director DSP With the first gene therapies now being on…Claire Otjes18 December 2018
BlogViral vaccinesViral vectors Novel HPLC assays allow for better biopharmaceutical development Written by expert: Gert, Associate Director Assays HPLC assays have been widely used to analyze…Claire Otjes4 August 2017